博拓生物(688767.SH):將繼續深耕聚焦POCT檢測賽道
格隆匯5月13日丨博拓生物(688767.SH)近日在接待機構投資者調研時表示,公司將繼續深耕聚焦POCT檢測賽道,充分發揮公司多年累積的技術、產品、質量、銷售優勢,在膠體金技術上推出性價比更高、靈敏度更高、更貼近客户使用需求的新產品。在新技術平台方面努力拓展免疫熒光產品種類,增加免疫熒光產品的註冊證書數量,通過微流控技術進一步提升產品品質,打造差異化優勢新技術產品。同時,公司在外沿努力尋找能夠形成產業協同及優勢互補標的,助力完善、擴充公司產品陣容,增強公司綜合競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.